Healthcare costs


Wanted! Cost-effective solutions in diabetes care

As daunting as the overall costs of diabetes are, the day-to-day challenge for individuals with diabetes and policy makers relates to choices in diabetes care. What benefits do various choices of intervention provide and at what cost? Whether these questions are asked at an individual or national level, knowing the answers is fundamental to cost-effectiveness.

Argentina's crisis triggers health emergency - The diabetes community's response

Diabetes affects an estimated 3.3% of the adult population in Argentina. For many of these people, insulin is a life-sustaining drug. Without uninterrupted access to insulin, people dependent on this drug for survival face the real possibility of death, some within days. The collapse of the reimbursement system and speculation have caused grave interruptions in the supply of medicines such as insulin and now an emergency response is expected from the Argentinean authorities.

Expensive new drugs: NICE or not so nice?

Around the world, healthcare services face increasing demands from aging populations, with high disease burdens and expensive new ways of managing them. Many new drugs and other health technologies cost considerably more than those they supplant, but may only give a proportionately small health gain. As a result individuals, insurance companies, health maintenance organizations and national health services are forced to take decisions on which new therapies can be afforded for whom.

Barriers to insulin accessibility: a hazard to life and health

For many people with diabetes insulin is essential to health. Indeed, there are few other conditions where the replacement of a hormone that the body has ceased producing can make an acute difference between life and death. Nevertheless, a recent data-gathering project in Central and Eastern Europe illustrated that, almost 80 years after its discovery, access to insulin supplies is still problematic.

Self-care: an important and cost-effective investment

The elevated cost of diabetes can be seen as the result of all previous failures of treatment. As illustrated in this article, treating diabetes complications is far more expensive than taking preventative measures. Future cost cutting, therefore, can only be achieved by improving the level of care, especially in the field of self-management. People with diabetes must be given the means to do this, which can only be attained by future investment.

Cost-effective approaches to diabetes care and prevention

Diabetes is one of the most costly diseases ever in both human and economic terms. To reduce today's burden and that on future generations, it is in everyone's interest that cost-effective measures to prevent diabetes are identified and implemented. The International Diabetes Federation (IDF) Task Force on Diabetes Health Economics has just completed a review of the evidence on cost-effective approaches to diabetes care and prevention. The timely publication shows that investment in diabetes care can be a cost-effective use of scarce resources. This article provides a brief summary.

Diabetes: its indirect costs. The costs of lost production

When someone is sick, be it short-term or long-term, we immediately think of the costs this person has to bear in terms of both physical pain and of the money needed to buy drugs and other supplies to get better or keep the condition under control. We might also go as far as to consider the financial costs borne by national healthcare systems. But there is more to health economics that this. Delve into this article to find out why we cannot remain blind to the so-called indirect costs of diabetes.

DEHKO: Finland moves on primary prevention

In January 2000, the Development Programme for the Prevention and Care of Diabetes 2000-2010 (DEHKO) was officially approved as Finland's national diabetes programme. The first audit of the programme in 2003 has reported that the implementation process is well underway in both primary and specialized healthcare. The atmosphere among healthcare providers is positive and enthusiastic, and the word DEHKO is now firmly established in the lexicon of diabetes care in Finland.

Diabetic eye disease: how you can watch out for it

Among the most feared diabetes complications are those affecting the eyes. Indeed, diabetes is the leading cause of partial vision loss and blindness in the working age population in many countries. The good news is that it does not have to be so.

Global danger from pharmaceutical regulation

Editor-in-Chief's editorial